Imanis Life Sciences provides contract research for vector-driven and immuno-oncology programs, covering viral vector research, virus and cell engineering, immunology, bioanalytical and cell-based assays, including p24 ELISA, NTA, functional titering, dPCR/qPCR, immunophenotyping, CAR-T characterization, and vector targeting. Supportruns from early discovery R&D through preclinical studies to clinical correlative assays, with collaborative, customizable study design.